Dr. Patrick Robert Dahl, MD

Dr. Dahl practices at Fullerton Clinical and Surgical Facility in Fullerton, California.

Dr. Dahl's NPI, 1033213392, was assigned on September 8, 2006. Dr. Dahl graduated from Stanford University School Of Medicine in 1991. Dr. Dahl holds California license G75823.

Dr. Dahl's primary practice is Fullerton Clinical and Surgical Facility, at 301 W Bastanchury Rd, Fullerton, CA 92835 in Orange County. The practice phone is (949) 706-2887.

Dr. Dahl's primary practice is Fullerton Clinical and Surgical Facility in Fullerton, California. Dr. Dahl is also affiliated with Providence St. Jude Medical Center. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Dahl to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahl practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dahl's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dahl is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dahl's licenses on file in 4 states: California, Arizona, Minnesota and Nevada.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, scalp rash, skin cyst and skin discoloration among the conditions Dr. Dahl treats.

CMS data shows 6,538 Medicare services from Dr. Dahl across 17 procedure codes in 2024, for 466 Medicare patients. Medicare paid $248,717 for them. Every service was in an office.

CMS counts 466 Medicare patients who saw Dr. Dahl in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dahl's median patient age at 75, with 44% women.

In 2024, Dr. Dahl wrote 363 Medicare Part D claims for 124 patients. 98% of them were for generic drugs. CMS names the drug for 281 of them, across 10 drugs with 11 or more claims each, at $4,846 in total drug cost. In 2023, CMS named 293 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dahl for performance year 2024, reported as part of a group. Dr. Dahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 475 procedures of skin biopsy by Dr. Dahl, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Dahl. The most frequent topics are Skin and Necrosis. Dr. Dahl has published most often in J Am Acad Dermatol. Dr. Dahl's most frequent co-authors are Mazen S. Daoud, MD, Kristina A. Holmkvist, MD and Charles Vincent Perniciaro, MD.

CMS Open Payments shows 8 general payments to Dr. Dahl from 5 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $250.

Dmand AI lists 4 awards for Dr. Dahl, most recently Top Doctors:LA Area in 2013.

Dr. Dahl graduated from Stanford University School Of Medicine in 1991. Dr. Dahl is a member of AAD.

Dr. Dahl is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.